INDICATED FOR INTRAVENOUS USE WITH MAGNETIC RESONANCE IMAGING (MRI) IN BRAIN (INTRACRANIAL), SPINE AND ASSOCIATED TISSUES IN ADULT AND PEDIATRIC PATIENTS (2 YEARS OF AGE AND OLDER) TO DETECT AND VISUALIZE AREAS WITH DISRUPTION OF THE BLOOD BRAIN BARRIER (BBB) AND/OR ABNORMAL VASCULARITY.
FOR ADULT AND PEDIATRIC PATIENTS (2 YEARS AND OLDER), THE RECOMMENDED DOSE OF DOTAREM IS 0.2 ML/KG (0.1 MMOL/KG) BODY WEIGHT ADMINISTERED AS AN INTRAVENOUS BOLUS INJECTION, MANUALLY OR BY POWER INJECTOR, AT A FLOW RATE OF APPROXIMATELY 2 ML/SECOND FOR ADULTS AND 1-2 ML/SECOND FOR PEDIATRIC PATIENTS.
FOR DETAILED DOSING GUIDELINES, SEE MONOGRAPH.